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Dermatologic Toxicities and 
Biological Activities of Chromium
Jumina Jumina  and Harizal Harizal
Abstract
Chromium is a versatile metal with various industrial applications and biological 
activities. However, as a transition metal, this element forms several species, i.e. 
oxidation states of −4 to +6, with different degrees of toxicities that affect ecosys-
tems and organisms including human beings. The skin is the outermost organ that 
usually interacts directly with chromium species in nature. These contact and inter-
action induce the formation of several acute and chronic negative effects including 
contact dermatitis, skin cancer, allergy, etc. In this chapter, toxicity and biological 
activity of several chromium species, such as chromium zero-valent, trivalent, 
hexavalent, will be reviewed to obtain better comprehension in chromium toxicity. 
Sources and routes of exposure, toxicity and possible treatment, and biological 
activity on the skin are arranged and explained systematically.
Keywords: chromium, skin, toxicities, biological activities, treatments
1. Introduction
Chromium is a unique transition metal with relatively high abundance on 
earth crust (1.4 × 10−2%). Chromium can form several species with different 
oxidation states from −4 to +6. Chromium with 0, +3, and +6 oxidation states 
are most commonly found and utilized in ambient conditions [1]. In industrial 
sectors, chromium-based materials have been used as coating material for corro-
sion resistant, pigments and dyes, wood preservatives, tanning agent, catalyst, 
and medical apparatus [1]. Chromium, especially for chromium(III), also showed 
certain biological activity especially in regulating carbohydrates and lipid metab-
olism [2, 3]. As an essential micronutrient, a low dietary of chromium will exhibit 
several adverse effects such as glucose intolerance, growth disorders, diminished 
longevity, etc. [3, 4].
Chromium toxicity has been a controversial problem due to its status as an 
essential micronutrient [5]. Various studies have shown that numerous acute and 
chronic adverse effects can be caused by any dermal or systemic exposure of chro-
mium species in human organ systems [6]. The toxicity and biological activity of 
chromium seem to be correlated directly with the concentration of corresponding 
chromium species [7]. In this case, chromium species have its optimum concentra-
tion to produce beneficial effects. Meanwhile, accumulation of less toxic chromium 
species in relatively high concentration will still produce a negative effect in the 
accumulation site [8, 9]. Chromium picolinate, for instance, has been mainly used 
as food supplement. Chromium(III) in this compound tend to accumulate in male 
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Sprague-Dawley rats’ cells over the period of investigation [10] and may be oxidized 
to more carcinogenic chromium(V) and chromium(VI) within the cells [11].
As the outermost organ that protects the human body from various pollutants, 
the skin is usually exposed to various sources of chromium, and it causes many 
dermatological acute and chronic negative effects such as contact dermatitis [12], 
systemic contact dermatitis [13], and possibly skin cancer [14]. In the same way, 
any topical or systemic administration of chromium compounds also can exhibit a 
beneficial effect for the skin such as antiacne [15], rapid wound healing [16], and 
anti-aging [17]. In this chapter, both toxicity and biological activity of chromium 
species in the skin are described starting from the source and route of exposure, 
toxicity and its possible treatment, and biological activity.
2. Source and exposure route of chromium in the skin
In modern life, chromium has been used in many forms and applications 
with Cr(0), Cr(III), and Cr(VI) as the main oxidation states. Various sources of 
chromium that affect or may affect the skin have been identified and tabulated in 
several review [12, 18, 19]. In general, exposure route of chromium that comes from 
these sources can be classified into two pathways including dermal and systemic 
pathways. In these cases, direct dermal exposure would cause contact dermatitis, 
irritation, and skin cancer, while systemic administration would elicit systemic 
contact dermatitis and skin tumor.
Dermal exposure (Figure 1) is initiated from direct contact of chromium 
sources on the skin. Chromium species are then accumulated on the skin surface 
or penetrated into the skin layers mediated by sweat or other biological fluids. The 
penetration of chromium species either as particulate or soluble forms occurred 
via three possible routes including transcellular by crossing the cell, intercellular 
by partitioning into the lipid matrix, and transappendageal by entering hair follicle 
and sebaceous glands [20, 21]. There are many factors involved in the penetration 
process including concentration of chromium species, medium (solvent and pH), 
intrinsic properties of chromium species (molecular volume of chromium species, 
counter ion, nature of chemical bond and polarity, solubility, and valence), reactiv-
ity towards protein, previous penetration or accumulation, skin characteristics 
(gender and race, age skin, density of sebaceous gland, thickness of skin, and 
anatomy of skin), and environmental factors (temperature, humidity, and UV 
radiation) [21, 22]. In a normal skin condition, Cr(VI) ions tend to have higher 
solubility [23] and percutaneous permeability than Cr(III) ions [24, 25]. However, 
Cr(III) have higher protein affinity to form metal-protein complex which tends to 
make it retain in the skin epidermis [26]. After penetrating the skin, Cr(VI) species 
are reduced by proteins or endogenous antioxidants to form Cr(III) [27] which then 
react further with any DNA or protein to form Cr(III)-protein complex as the actual 
allergen (haptens) [28].
In systematic exposure, chromium mostly enter the human body via oral 
consumption of certain chromium sources such as food or food supplement [29], 
foodstuff [30], and drinking water [31] or from applications of chromium-based 
implants [32]. In the digestive system, most of Cr(III) consumed are excreted to 
feces and some of it (~2%) is absorbed by epithelial cells covering the stomach and 
enterocytes covering the intestines through passive absorption (diffusion) [33]. 
This absorption was affected (increased or decreased) by the presence of various 
ligand such as amino acids, vitamins, carbohydrates, plasma proteins, certain met-
als, and other chelating agents [34]. After the absorption, Cr(III) complex would be 
accumulated inside the cells or actively transported to the blood stream by still an 
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unknown transporter. Cr(III) ions then bound to transferrin (siderophilin) or other 
plasma proteins in the blood stream and travel to the whole body [33, 34].
3. Toxicities of chromium
3.1 Contact dermatitis
Contact dermatitis is a common skin disease caused by repeated dermal contact 
with certain allergens (haptens) leading to delayed-type hypersensitivity effect 
[35]. Many haptens have been identified to cause contact dermatitis such as metals, 
fragrances, and flavors, preservatives, plastics, rubber, pharmaceutical, cosmet-
ics, woods and plants, textile, etc. [35]. Chromium-induced contact dermatitis is 
characterized by the presence of certain clinical manifestations in feet and hands. 
Acute dermatitis is usually indicated by the formation of erythema, oedema, pap-
ules, vesicles, and weeping, while chronic dermatitis tends to form scaly, dry, and 
fissured skin [36]. Various chromium-induced contact dermatitis cases have been 
reported involving different chromium sources such as cement [37, 38], leather 
[38–43], tattoo ink [44], cellular phone [45, 46], etc. Concentration threshold for 
soluble chromium in each chromium-containing product should not exceed 1 ppm 
to minimize elicitation of contact dermatitis [47].
In general, chromium-induced contact dermatitis is formed through several steps 
which can be described as the following (Figure 2) [48, 49]: initially, after penetrat-
ing the skin, Cr(VI) ions are reduced by endogenous antioxidant to form Cr(III) 
Figure 1. 
Several pathways of dermal exposure: (A) deposition of Cr(VI) in the skin surface causes irritation or 
chemical burn; (B) penetration of Cr(VI) through transcellular and intercellular pathways induces cell 
apoptosis and contact dermatitis, while Cr(III) tend to suspended in the skin surface due to strong affinity 
to skin protein; (C) deeper penetration to blood stream causes organ disruptions, (D) Cr species from 
systemic administration trigger systemic contact dermatitis, (E) deposition of Cr species on hair causes hair 
discoloration; (F) penetration of Cr species into hair follicle induces rapid hair fall. Figure is drawn using 
ChemBioDraw Ultra version 14.0 software.
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and oxygen reactive species (ROS). Cr(III) as the real allergen is bound to certain 
proteins to form the hapten, while ROS induces the releasing of interleukin-1β (IL-
1β) which then activates antigen-presenting cells (Langerhans cells (LC)). Activated 
antigen-presenting cells bind with the hapten, mature, travel to the regional lymph 
nodes, and stay in paracortical T-cell areas. After that, activated antigen presenting 
cells-hapten complex activates naïve T cells by helping in vigorous blast formation 
and proliferation to become chromium-specific T cells. Activated chromium-spe-
cific T cells then travel through blood stream and recirculate to give hypersensitivity 
effect detecting a lower concentration of hapten in different parts of the skin.
Treatment of chromium-induced contact dermatitis could be conducted in 
several approaches including avoiding direct contact to chromium source and topical 
application of chelating agent and barrier creams to prevent any cutaneous perme-
ation, corticosteroid to relieve inflammation, and antioxidant to reduce oxidative 
stress [36, 50]. Various antioxidants have been tested in treating chromium-induced 
contact dermatitis such as N-acetylcysteine [51], ascorbic acid [52], pine bark extract 
(pycnogenol®) [53], and pterostilbene [54]. Two chelating agents, ethylenediami-
netetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA), also 
have been examined for preventing contact dermatitis, but both of these ligands 
showed a low effectiveness as a protecting agent [55, 56]. The developments in 
Figure 2. 
Simplified elicitation mechanism of chromium-induced contact dermatitis adapted from several references [48, 49].
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chromium-induced contact dermatitis are still widely opened. These developments 
could be focused on finding natural antioxidant and chelating agents that effectively 
relieve oxidative stress and reduce the reactivity of chromium ions, respectively.
3.2 Systemic contact dermatitis
Systemic contact dermatitis is a kind of dermatitis elicited by systemic adminis-
tration of certain allergen that previously sensitizes the skin through direct dermal 
contact [57]. Several groups of allergens have been identified to cause this inflam-
matory disease such as metals, medications, food, plants and herbals, and certain 
chemicals [57, 58]. Systemic administration of these allergens is also described in 
various routes including oral, subconjunctival, intramuscular, pulmonary inhala-
tion, intranasal, intrauterine, endocardial, arthroplastic, intravenous, intraar-
ticular, subcutaneous, intradermal, dental, intratubal, and endovascular [59]. The 
pathophysiology of this disease still remains unclear, but several mechanisms have 
been proposed [60–65]. Moreover, the theory suggesting type 3 immune response 
(antigen-antibody complexes) involved in systemic contact dermatitis (SCD) has 
not fully been proven [58].
Chromium as a metal allergen has been found to cause systemic contact derma-
titis either through oral, dental, or arthroplastic routes [13, 66, 67]. Consumption of 
Cr(III)-based supplements in the form of chromium picolinate [68] and chromium 
chloride [69] has been shown to cause SCD. Oral ingestion of potassium dichromate 
previously used as a homeopathic drug also induces dermatitis as clinical manifesta-
tion of SCD [70, 71]. In certain case, SCD is also induced by various metal alloys 
applied in orthopaedical, cardiac, neurological, and abdominal associated devices 
[72]. In these cases, chromium-containing alloys such as stainless steel SAE 316 L, 
cobalt-chromium-molybdenum steel, and Vitalium™ release metal ion [73] are 
reported to cause SCD [74–79]. These reported SCD cases are identified with the 
presence of several manifestations including erythroderma [74], and localized/gen-
eralized eczema or urticarial [76–78]. These findings suggested that any chromium 
sources applied in systemic routes could elicit SCD with certain clinical manifesta-
tions and degrees of severity.
Treatment of chromium-induced systemic contact dermatitis may be conducted 
in several approaches including managing diets and lifestyles by gut remediation 
and avoiding the food and sources that contain chromium; systemic or topical treat-
ment using immune-suppressants such as corticosteroid; phototherapy; and hypo-
sensitization therapy [80, 81]. Sharma developed a guideline for the preparation of 
low chromate diet that could help in controlling daily chromium consumption from 
food and ameliorating skin condition [82]. In case of SCD from arthroplastic routes, 
revision or removal of implant needs to be conducted by considering the time of 
hypersensitivity incidence after surgery and degree of severity [74]. Revision of 
implant could be conducted by using less allergenic implant such as titanium-based 
implant or chromium-based implant coated with certain biocompatible materials 
such as polytetrafluoroethylene, ZrN multilayers, diamond-like carbon, titanium 
nitride, graphite-like carbon, and tantalum [74, 79, 83]. Revision or removal of 
implants may not produce rapid disappearance [76] probably due to the presence of 
soluble or particulate debris of implant that produce inflammations [84, 85].
3.3 Skin cancer
Chromium, especially Cr(VI), is a potent human carcinogen. In a human cell, 
carcinogenesis of chromium(VI) (Figure 3) occurs through the penetration of 
chromium(VI) species into the cell via sulphate/phosphate anion transport system, 
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reduction of chromium(VI) by endogenous antioxidant to produce ROS and 
chromium(III), and alteration of DNA directly by chromium(VI) or indirectly by 
ROS [86]. The alteration of DNA then produces different types of products includ-
ing Cr-DNA adducts, DNA–protein and DNA interstrand cross-links, DNA breaks, 
and DNA base damage [87]. Carcinogenicity of chromium(VI) has induced lung 
cancer in workers from various chromium-based industries [88–90] and has been 
associated to incidence of other cancers [91]. However, the meta-analysis study 
showed that the correlation between exposure of chromium(VI) and the high 
mortality in skin cancer is not significant [91]. This study indicated that there is no 
supporting data confirming the chromium species as carcinogen in inducing skin 
cancer in human.
Several studies, however, showed that chromium species could induce skin 
cancer in rats and mice either as single carcinogen or cocarcinogen. Oral adminis-
trations of drinking water containing sodium dichromate dehydrate to male F344/N 
rats for 2 years showed that the sample developed various types of skin cancer [92]. 
Two other studies using hairless SK1-hrBR mice also exhibited that chromium(VI) 
could act as cocarcinogen in promoting UV-induced skin tumor [93, 94]. Davidson 
and co-workers [93] showed that oral administration of chromium(VI)-containing 
drinking water and UV irradiation to hairless mice have synergistic effect in 
promoting skin tumor. Exposure of chromium(VI) or UV radiation alone did not 
induce skin tumors [93]. Uddin and co-worker also conducted the same experi-
ment and found that systemic administration of exogenous antioxidant (vitamin 
E and selenomethionine) did not improve skin condition [94]. It indicated that 
chromium(VI) cocarcinogenicity may be occurred in different mechanisms without 
involving ROS [94]. These three studies indicate that acute or chronic oral admin-
istration of chromium(VI) species has a great potency in promoting skin cancer in 
mammals including humans.
Figure 3. 
Simplified mechanism of chromium carcinogenesis adapted from several references [86, 95].
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3.4 Irritation and chromium burn
Irritation and chemical burn are caused by dermal exposure of chromium(VI) 
particle, solution, or mist in large quantities. Solid deposition of chromium(VI) 
would develop to “chromium ulcers” or “chrome holes” [67], while high concentra-
tion of chromium(VI) solution would lead to chromium burn. A mechanism for 
this ulcer formation is still unclear, but it may be related to the disruption of actin 
cytoskeleton by chromium(VI) leading to mitochondria-dependent apoptosis in 
skin fibroblasts cells [96]. Several reports exhibited these irritation and burning 
effects from different chromium species such as solid CrO3 [97], chromic acid solu-
tion [98–100], hot chromium(III) sulphate solution [101, 102], and chromium acid 
mist [103].
Management of irritation is conducted by considering preventive and treatment 
approaches. Prevention of irritation is conducted by using barrier creams, moistur-
izers, etc., while treatment could be done by using moisturizers and corticosteroids 
[50]. For chromium burn, treatment is conducted by combining mechanical exci-
sion, hemofiltration, and systemic administration of chelating agent and antioxi-
dant [100].
3.5 Hair disorders
Human hair is naturally exposed to a certain amount of chromium [104] that 
come from various sources [105–107]. Excessive and repeated exposures of chro-
mium in certain environmental condition cause discoloration of blond, dyed-blond, 
and white hair (to become green) [108–110] and cause rapid hair fall [111, 112]. 
The mechanisms of these two effects are still unclear. Hair discoloration is prob-
ably the result of interaction between chromium ions (and also copper and nickel) 
and protein in hair (keratin) [113], while rapid hair fall may be related to several 
mechanisms such as promoting premature end of hair cycle [114] or disruption of 
hair shaft formation [115].
4. Biological activities of chromium
4.1 Acne vulgaris (antiacne)
Acne vulgaris is a common dermatological condition that affects physical and 
psychological aspects of patients [116]. Several diseases that show the presence of 
a certain degree of acne also relate with depression and emotional stress such as 
type-2 diabetes, rheumatoid arthritis, and polycystic ovarian syndrome (PCOS) 
[117–119]. Pathophysiology of this disease involves several key mechanisms includ-
ing excessive sebum production due to hormonal and environmental conditions, 
alteration of fatty acids composition due to sebum metabolism by Cutibacterium 
acnes, hyperkeratinization within the follicle that clogs up the pore in the form of 
whitehead or blackhead comedones, inflammation induced by bacterial coloniza-
tion, and malfunction of locale innate and adaptive immune system [120]. The 
presence of acne vulgaris is also correlated to the clinical depression in patients 
[116]. In this case, depression or stress can influence the regulation of sebaceous 
gland as the main part in sebum production [121]. Catecholamines (epinephrine 
and norepinephrine) as the main stress hormones also affect the growth of certain 
Cutibacterium acnes strains [122–124]. Catecholamine-treated C. acnes strain also 
can stimulate a limited but significant increase of lipid production in sebaceous 
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gland. However, the increase of intrinsic cytotoxicity or inflammatory potential of 
C. acnes is statistically significant [124].
Several reports exhibited that certain chromium(III) compounds have high 
activity in improving acne vulgaris. Initially, chromium has been used in the form 
of high-chromium yeast or chromium GTF (glucose tolerance factor) by consum-
ing 400 μg chromium daily which exhibited comparable improvement in acne 
conditions [15]. This form of treatment, recently, is considered as a complementary 
and alternative medicine (CAM) for the treatment of acne vulgaris [125]. Further 
improvements used different chromium compounds including chromium picolinate 
[126, 127] and chromium salt such as chromium (III) chloride [128].
In most cases, the usage of chromium compound as antiacne is usually com-
bined with other active compounds such as vitamins, certain minerals, and herbal 
medicine sources in the form of oral [129–131] or topical [128] formulation to get 
more effective treatment results. Application of topical formulation containing 
chromium (III) chloride and magnesium sulphate showed total improvement in 
acne vulgaris with temporal mild to moderate irritation as a side effect [128]. Oral 
capsule containing methionine-bound zinc complex, chromium, and vitamins 
also exhibited 80–100% improvements for mild to moderate acne vulgaris [131]. 
In another study, a combination of several nutrients with potential antiacne and 
anti-depressant properties (eicosapentaenoic acid, epigallocatechin-3-gallate, zinc 
gluconate from green tea extract, selenium, and chromium) may also improve 
inflammatory acne lesions and mood aspect of patients [132].
Treatment of acne vulgaris in polycystic ovary syndrome (PCOS) showed mix 
results. A study by Amr and Abdel-Rahim showed that using 200 μg/day oral con-
sumption for 8 weeks has no significant improvement in acne and hirsutism [126]. 
In a different study, chromium supplementation by women with polycystic ovary 
syndrome (PCOS) in a randomized, double-blind, placebo-controlled trial exhib-
ited that the treatment gives beneficial effects on acne and hirsutism using 1000 μg/
day oral consumption for 6 months [127]. These two studies indicated that the 
treatment of acne vulgaris in PCOS patients needs greater dose and longer duration.
Action mode of chromium in ameliorating acne vulgaris has not been fully 
elucidated yet, but there are two mechanisms proposed including (1) by decreas-
ing serum testosterone concentration and (2) lowering the depression of patients. 
In the first mechanism, chromium can decrease serum testosterone level possibly 
due to the reduction of testicular steroidogenic enzymes activities [133]. In this 
case, a lower level of serum testosterone reduces sebum production in sebaceous 
glands [134]. The second mechanism explains that chromium as an anti-depressant 
[135–137] may reduce sebum production [138] and affect C. acnes growth in 
sebaceous glands [122–124]. It is clearly showed that these two mechanisms may 
have direct or indirect synergistic effects [139] in ameliorating skin condition with 
acne vulgaris.
4.2 Cutaneous ageing (anti-ageing)
Aging is a complex multifactorial process of damage accumulation that 
causes the deterioration of fitness [140, 141]. Aging has been the main risk fac-
tor for several deadly diseases such as cancer, cardiovascular disease, diabetes, 
and neurodegeneration [141]. In the skin, aging is identified by the presence of 
folds and wrinkles due to the declining and degradation of collagen [142], loss of 
elasticity [143], and decreasing of various skin functions [144]. At least, there are 
seven factors that may produce these clinical manifestations including passage 
of time, genetics, radiation such as ultraviolet and infrared radiations, lifestyle, 
chronic debilitating diseases, dysfunction of hormonal system, and gravitational 
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force [145]. Several mechanisms have been proposed to explain the effect of 
these factors on aging including oxidative stress, telomere shortening, epigenetic 
dysregulation, DNA damage, genetic mutation, inflammation, mitochondrial 
dysfunction, and accumulation of glycation end product [146, 147].
Treatment for skin aging can be conducted through three approaches including 
adjusting lifestyle by routine exercise, calorie restriction, and maintaining mental 
health; gene therapies; and medications. Among other approaches, medication could 
be the simplest approach in fighting skin aging such as by using topical or systemic 
agents [148]. Chromium as dietary supplement (50–200 μg) has been used in prevent-
ing skin aging by controlling and regulating blood sugar and lipid levels [17]. Either 
in topical or systemic applications, chromium is usually combined with different 
vitamins and minerals to obtain optimum results based on certain parameters such 
as improving insulin function using chromium picolinate [149], promoting mito-
chondrial biogenesis and lipid metabolism using oligomannuronate-chromium(III) 
complexes [150], replacing or removing excess iron production using chromium(III) 
chloride or chromium picolinate [151, 152], and activating telomerase [153].
Antioxidant activity of chromium may also contribute to its anti-aging 
properties since oxidative stress has a certain role in the damaging process. 
Supplementation of chromium(III) in adult male and female with type-2 diabetes 
mellitus minimized the increase of oxidative stress (thiobarbituric acid reactive 
substances—TBARS) and increased total antioxidant status [154, 155]. Several com-
binations have been made by formulating chromium(III) with zinc [156], niacin 
[157], and vitamin C/E [154] and showed a protective effect against skin damage 
against oxidative stress.
Antioxidant activity of chromium(III) is correlated to the dose applied as shown 
in several experiments. Incubation of BALB/3 T3 clone A31 cells and HepG2 cells 
with chromium(III) chloride concentration higher than 400 μM would induce 
the formation of oxidative stress, while lower optimized concentration (M = 100–
200 μM) would increase superoxide dismutase and catalase antioxidant activities 
[7]. In vitro study on the effect of chromium(III) and chromium(VI) on catalase 
activity also showed this dose-dependent activity in which treatment of cell-free 
catalase using chromium(III) (dose range 1–5 × 10−5 mol/L) and chromium(VI) 
(dose range 1–4 × 10−5 mol/L) separately increased the catalase activity [158]. These 
two studies clearly describe that either chromium(III) or chromium(VI) has a 
certain optimum concentration to exhibit their beneficial effects.
4.3 Cutaneous wound (rapid wound healing)
Cutaneous wound is the skin defect or skin opening that is caused by external 
forces [159]. Formation of this wound triggers a set of complex biochemical pro-
cesses to repair the damage that are called as wound healing or wound repair. In nor-
mal condition, there are five consecutive phases occurred in wound healing process 
including (1) homeostasis phase (immediately) through the migration of thrombo-
cytes and formation of fibrin clot to stop the bleeding; (2) first inflammatory phase 
(day 1–day 6) by sensing the injury, sending the danger signal, and initializing the 
inflammation; (3) second inflammatory phase (day 1–day 6) through elimination 
the pathogens and cleaning the wound; (4) proliferation phase (day 4–day 14) 
through epithelialization, angiogenesis, granulation tissue formation, and collagen 
deposition to repair the damage and initialize the tissue remodeling process; and (5) 
remodeling phase (day 8–year 1) through the deposition of collagen to reach matu-
ration of tissue structure [160–162]. Several internal and external factors have been 
identified to affect the wound healing process including oxygenation, infection and 
foreign body, lifestyle, hormonal effect, age, and gender [163].
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Several studies have shown that chromium(III), in a certain condition, could 
improve cutaneous wound either in normal or diabetic Wistar rats using a single dose 
of a combination of zinc(II) (1.5 mg/kg weight) and chromium(III) (0.02 mg/kg 
weight) [164] and C57BL6/J mice using chromium(III) chloride (80 μg/kg weight/
day) for 21 days [16]. The mechanism of this effect has not been fully elucidated 
yet, but it may be related to chromium(III) activity in increasing insulin sensitivity, 
insulin-like growth factor 1 (IGF-1) serum concentration, and protein deposition 
[16, 165]. In this case, high glucose concentration could inhibit proliferation and dif-
ferentiation of skin keratinocytes [166] and increase the stiffness of collagen [167] 
which further inhibits wound healing. In healing acetic acid-induced colitis wound, 
chromium(III) also acted as an anti-inflammatory agent by inhibiting several 
inflammatory markers and downregulating pro-inflammatory cytokine genes and 
antioxidant by suppressing oxidative stress without any significant side effect [168].
In different situations, the use of chromium-based skin clips [169] and orthope-
dic implant [74] gave an adverse effect by delaying surgery wound healing process. 
These cases represented a hypersensitivity effect as a manifestation of systemic 
contact dermatitis. In vitro study using human skin keratinocyte cell line (HaCaT 
cells) in a medium containing chromium(III) solution (10−6 M) showed that 
chromium(III) ions can decrease wound closure rate and be further decreased when 
the medium was replaced with another chromium(III) ion-containing medium 
[170]. Chromium(III) ions also caused downregulation of toll-like receptor-2, 
-4, and -9 messenger ribonucleic acids (TLR-2, -4, and -9 mRNA), upregulation 
of matrix metalloproteinase 2 and 13, and upregulation of intercellular adhesion 
molecule 1 messenger ribonucleic acid (ICAM-1 mRNA) [170].
There’s no exact explanation for these opposite effects. However, it may be 
related to the local concentration of chromium species in wound location. An 
enhancing effect of wound healing was obtained by applying a relatively small 
concentration of chromium species via oral administration. In human, for instance, 
there is only 2% of oral chromium(III) that will be absorbed through stomach and 
intestine and distributed throughout the body. In the same time, an adverse effect 
was obtained when local chromium concentration was high due to a particulate and 
soluble chromium released from the implants.
5. Conclusions
Chromium as versatile heavy metals showed contradictive properties dealing 
with its dermatologic toxicity and biological activity properties. The main factors 
that probably correlate to these properties are concentrations and species of chro-
mium. Significant increment of local chromium concentration (more than 1 ppm 
for chromium[VI] species) either from dermal or systemic administration would 
increase the risk of dermatologic toxicities, while topical or oral administration of 
small recommended dietary concentration of chromium (50–200 μg for chromium 
picolinate) would give several beneficial effects. More studies need to be conducted 
to know the exact effect of the local concentration of corresponding chromium 
species in many systems.
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